Michael Cruse - Insider Trading & Ownership

Entity
Individual
Location
C/O Reneo Pharmaceuticals, Inc., 12230 El Camino Real, Suite 230, San Diego, CA
Summary
The estimated net worth of Michael Cruse is at least $310K dollars as of December 13, 2022. Michael Cruse is the Chief Operating Officer of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $310K.
All Insider Reports
All Insider Reports

Ownership of Michael Cruse

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OKUR OnKure Therapeutics, Inc. Chief Operating Officer $310K Dec 9, 2022

Insider Transactions Reported by Michael Cruse:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.